Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump (STAR Trial)

NCT07644247 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT07644247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07644247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump (STAR Trial)
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Phase 4
Overall status
Not yet recruiting
Start date
June 25, 2026
Completion date
December 31, 2029
Enrollment
370 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antiplatelet therapy, antithrombotic therapy, aspirin, bleeding, hemocompatibility-related adverse event, lvad, lvad (left ventricular assist device), lvad (left ventricular assist device) thrombosis, lvad-related gi bleed, stroke, thrombosis, ventricular assist device